- Home
- SLS vs FORR Comparison
SLS vs FORR Comparison
Compare SLS & FORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLS | FORR |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 169.1M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | SLS | FORR |
|---|---|---|
| Price | $1.54 | $7.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 110.5K |
| Earning Date | 11-12-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $403,871,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.77 | $6.62 |
| 52 Week High | $2.48 | $17.51 |
Technical Indicators
Market Signals| Indicator | SLS | FORR |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 41.36 |
| Support Level | $1.39 | $6.94 |
| Resistance Level | $1.64 | $7.50 |
| Average True Range (ATR) | 0.12 | 0.37 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 57.69 | 33.69 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.